Evolent Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,889	1,876	2,555	1,964	1,352	907.96
Revenue Growth (YoY)	-21.26%	-26.56%	30.09%	45.26%	48.91%	-1.80%
Cost of Revenue	1,508	1,476	2,187	1,503	1,035	657.55
Gross Profit	381.19	399.88	367.35	460.47	316.58	250.41
Selling, General & Admin	298.28	303.87	263.05	358.11	269.27	219.5
Depreciation & Amortization Expenses	113.35	115.85	118.37	123.42	67.2	60.04
Other Operating Expenses	388.68	390.3	26.42	50.16	-23.52	13.28
Total Operating Expenses	800.3	810.02	407.84	531.68	312.94	292.82
Operating Income	-419.12	-410.14	-40.49	-71.21	3.64	-42.41
Interest Income	3.93	4.19	5.54	5.26	1.37	0.41
Interest Expense	-63.95	-57.47	-24.72	-54.21	-15.57	-25.43
Other Non-Operating Income (Expense)	-14.41	-71.22	-3.37	-82.25	-51.52	37.63
Total Non-Operating Income (Expense)	-74.43	-124.5	-22.55	-131.19	-65.72	12.61
Pretax Income	-497.21	-534.64	-63.04	-202.41	-62.08	-29.8
Provision for Income Taxes	-0.69	-0.13	-1.41	-89.37	-43.38	0.48
Net Income	-533.78	-579.4	-93.45	-142.26	-19.16	-37.6
Net Income Attributable to Preferred Dividends	-37.26	-44.89	-31.83	-29.22	-	-
Earnings From Discontinued Operations	-	-	-	-	-0.46	-7.32
Net Income to Common	-533.78	-579.4	-93.45	-142.26	-19.16	-37.6
Shares Outstanding (Basic)	113	114	115	111	94	86
Shares Outstanding (Diluted)	113	114	115	111	94	86
Shares Change (YoY)	-1.40%	-0.41%	3.08%	18.73%	8.87%	1.34%
EPS (Basic)	-4.76	-5.07	-0.81	-1.28	-0.20	-0.44
EPS (Diluted)	-4.76	-5.07	-0.81	-1.28	-0.20	-0.44
Shares Outstanding	112.48	111.6	116.56	113.89	99.96	89.22
Free Cash Flow	1.4	4.76	-6.13	113.84	-49.91	13.76
Free Cash Flow Growth	-70.66%	-	-	-	-	-
Free Cash Flow Per Share	0.01	0.04	-0.05	1.02	-0.53	0.16
Gross Margin	20.18%	21.31%	14.38%	23.45%	23.42%	27.58%
Operating Margin	-22.19%	-21.86%	-1.58%	-3.63%	0.27%	-4.67%
Profit Margin	-26.38%	-28.49%	-2.41%	-5.76%	-1.38%	-3.34%
FCF Margin	0.07%	0.25%	-0.24%	5.80%	-3.69%	1.52%
EBITDA	-305.77	-294.29	77.89	52.2	70.84	17.63
EBITDA Margin	-16.19%	-15.68%	3.05%	2.66%	5.24%	1.94%
EBIT	-419.12	-410.14	-40.49	-71.21	3.64	-42.41
EBIT Margin	-22.19%	-21.86%	-1.58%	-3.63%	0.27%	-4.67%
Effective Tax Rate	0.14%	0.02%	2.24%	44.15%	69.87%	-1.62%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q